Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

NAFLD in PCOS patients is linked to early kidney problems.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

The combination of Stemoxydine® and Resveratrol improves hair density in women with Female Pattern Hair Loss.

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Juniperus sabina L. extract shows potential medicinal value due to high podophyllotoxin levels and strong anti-butyrylcholinesterase activity.

Using a handheld massage device during hair transplant significantly reduces pain for most patients.

Children's screen time increased during the pandemic, causing various health issues.

Melatonin improves tomato root growth and plant health at certain levels by affecting genes and hormones but can damage roots at high levels.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Lower melatonin levels are linked to more skin aging.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.